Cargando…

Cd34 Immunostaining Adds Specificity To Microvascular invasion Analysis in Hepatocellular Carcinoma

INTRODUCTION: Hepatocellular carcinoma is the most common primary neoplasia of the liver. Microvascular invasion predicts outcome and defines tumor staging. However, its diagnosis is still a challenge. The present study aims to evaluate inter and intraobserver agreement in identifying the presence o...

Descripción completa

Detalles Bibliográficos
Autores principales: Gama, Henrique, Albuquerque, Ronniel, Campos Wanderley, David, Pascoal Xavier, Marcelo Antônio, Osório, Fernanda Maria Farage, Couto, Cláudia Alves, Ferrari, Teresa Cristina de Abreu, Lima, Agnaldo S, Diniz, Paulo Henrique Costa, Vidigal, Paula Vieira Teixeira
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9879024/
https://www.ncbi.nlm.nih.gov/pubmed/36711001
http://dx.doi.org/10.2147/JHC.S389836
_version_ 1784878613542207488
author Gama, Henrique
Albuquerque, Ronniel
Campos Wanderley, David
Pascoal Xavier, Marcelo Antônio
Osório, Fernanda Maria Farage
Couto, Cláudia Alves
Ferrari, Teresa Cristina de Abreu
Lima, Agnaldo S
Diniz, Paulo Henrique Costa
Vidigal, Paula Vieira Teixeira
author_facet Gama, Henrique
Albuquerque, Ronniel
Campos Wanderley, David
Pascoal Xavier, Marcelo Antônio
Osório, Fernanda Maria Farage
Couto, Cláudia Alves
Ferrari, Teresa Cristina de Abreu
Lima, Agnaldo S
Diniz, Paulo Henrique Costa
Vidigal, Paula Vieira Teixeira
author_sort Gama, Henrique
collection PubMed
description INTRODUCTION: Hepatocellular carcinoma is the most common primary neoplasia of the liver. Microvascular invasion predicts outcome and defines tumor staging. However, its diagnosis is still a challenge. The present study aims to evaluate inter and intraobserver agreement in identifying the presence of microvascular invasion using conventional and immunohistochemistry histology. METHODS: Three pathologists performed the analysis of 76 hepatocellular carcinoma explants to characterize the presence of microvascular invasion using the hematoxylin/eosin stain and immunohistochemistry for CD34. The evaluations were made individually, in two distinct moments. Results were analyzed by the Kappa’s coefficient and ROC curves. RESULTS: Our study demonstrated similar agreement for microvascular invasion between hematoxylin/eosin and CD34 methods. However, the intraobserver agreement values for both methods were higher than the interobserver ones. The accuracy of CD34 in relation to hematoxylin/eosin by ROC curves in intraobserver analysis tends to a high specificity, ranging from 82.1 to almost 100%, with sensitivity of 46.9% to 81.1%. In interobserver analysis, CD34 also has a high specificity (84.3% to 85.5%) while its sensitivity is a little shorter (81.2% to 84.3%). CONCLUSION: Intraobserver higher agreement allows us to suppose that pathologists employed own criteria to evaluate vascular invasion, reinforcing the need of standardization. ROC Curves analysis showed that the CD34 method is more specific than sensitive. Therefore, immunohistochemistry for CD34 should not be used routinely, but it could be useful to help confirming invasion previously seen by conventional histology.
format Online
Article
Text
id pubmed-9879024
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-98790242023-01-27 Cd34 Immunostaining Adds Specificity To Microvascular invasion Analysis in Hepatocellular Carcinoma Gama, Henrique Albuquerque, Ronniel Campos Wanderley, David Pascoal Xavier, Marcelo Antônio Osório, Fernanda Maria Farage Couto, Cláudia Alves Ferrari, Teresa Cristina de Abreu Lima, Agnaldo S Diniz, Paulo Henrique Costa Vidigal, Paula Vieira Teixeira J Hepatocell Carcinoma Original Research INTRODUCTION: Hepatocellular carcinoma is the most common primary neoplasia of the liver. Microvascular invasion predicts outcome and defines tumor staging. However, its diagnosis is still a challenge. The present study aims to evaluate inter and intraobserver agreement in identifying the presence of microvascular invasion using conventional and immunohistochemistry histology. METHODS: Three pathologists performed the analysis of 76 hepatocellular carcinoma explants to characterize the presence of microvascular invasion using the hematoxylin/eosin stain and immunohistochemistry for CD34. The evaluations were made individually, in two distinct moments. Results were analyzed by the Kappa’s coefficient and ROC curves. RESULTS: Our study demonstrated similar agreement for microvascular invasion between hematoxylin/eosin and CD34 methods. However, the intraobserver agreement values for both methods were higher than the interobserver ones. The accuracy of CD34 in relation to hematoxylin/eosin by ROC curves in intraobserver analysis tends to a high specificity, ranging from 82.1 to almost 100%, with sensitivity of 46.9% to 81.1%. In interobserver analysis, CD34 also has a high specificity (84.3% to 85.5%) while its sensitivity is a little shorter (81.2% to 84.3%). CONCLUSION: Intraobserver higher agreement allows us to suppose that pathologists employed own criteria to evaluate vascular invasion, reinforcing the need of standardization. ROC Curves analysis showed that the CD34 method is more specific than sensitive. Therefore, immunohistochemistry for CD34 should not be used routinely, but it could be useful to help confirming invasion previously seen by conventional histology. Dove 2023-01-22 /pmc/articles/PMC9879024/ /pubmed/36711001 http://dx.doi.org/10.2147/JHC.S389836 Text en © 2023 Gama et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Gama, Henrique
Albuquerque, Ronniel
Campos Wanderley, David
Pascoal Xavier, Marcelo Antônio
Osório, Fernanda Maria Farage
Couto, Cláudia Alves
Ferrari, Teresa Cristina de Abreu
Lima, Agnaldo S
Diniz, Paulo Henrique Costa
Vidigal, Paula Vieira Teixeira
Cd34 Immunostaining Adds Specificity To Microvascular invasion Analysis in Hepatocellular Carcinoma
title Cd34 Immunostaining Adds Specificity To Microvascular invasion Analysis in Hepatocellular Carcinoma
title_full Cd34 Immunostaining Adds Specificity To Microvascular invasion Analysis in Hepatocellular Carcinoma
title_fullStr Cd34 Immunostaining Adds Specificity To Microvascular invasion Analysis in Hepatocellular Carcinoma
title_full_unstemmed Cd34 Immunostaining Adds Specificity To Microvascular invasion Analysis in Hepatocellular Carcinoma
title_short Cd34 Immunostaining Adds Specificity To Microvascular invasion Analysis in Hepatocellular Carcinoma
title_sort cd34 immunostaining adds specificity to microvascular invasion analysis in hepatocellular carcinoma
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9879024/
https://www.ncbi.nlm.nih.gov/pubmed/36711001
http://dx.doi.org/10.2147/JHC.S389836
work_keys_str_mv AT gamahenrique cd34immunostainingaddsspecificitytomicrovascularinvasionanalysisinhepatocellularcarcinoma
AT albuquerqueronniel cd34immunostainingaddsspecificitytomicrovascularinvasionanalysisinhepatocellularcarcinoma
AT camposwanderleydavid cd34immunostainingaddsspecificitytomicrovascularinvasionanalysisinhepatocellularcarcinoma
AT pascoalxaviermarceloantonio cd34immunostainingaddsspecificitytomicrovascularinvasionanalysisinhepatocellularcarcinoma
AT osoriofernandamariafarage cd34immunostainingaddsspecificitytomicrovascularinvasionanalysisinhepatocellularcarcinoma
AT coutoclaudiaalves cd34immunostainingaddsspecificitytomicrovascularinvasionanalysisinhepatocellularcarcinoma
AT ferrariteresacristinadeabreu cd34immunostainingaddsspecificitytomicrovascularinvasionanalysisinhepatocellularcarcinoma
AT limaagnaldos cd34immunostainingaddsspecificitytomicrovascularinvasionanalysisinhepatocellularcarcinoma
AT dinizpaulohenriquecosta cd34immunostainingaddsspecificitytomicrovascularinvasionanalysisinhepatocellularcarcinoma
AT vidigalpaulavieirateixeira cd34immunostainingaddsspecificitytomicrovascularinvasionanalysisinhepatocellularcarcinoma